ERNA icon

Eterna Therapeutics
ERNA

Overview Fund Activity

26 hedge funds and large institutions have $264K invested in Eterna Therapeutics in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TSS
Two Sigma Securities
New York
+$35.5K
2
Citigroup
Citigroup
New York
+$27.3K
3
VPIM
Vanguard Personalized Indexing Management
California
+$12K
4
Citadel Advisors
Citadel Advisors
Florida
+$11.7K
5
HF
HRT Financial
New York
+$7K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$13.2K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9.16K
3
CSS
Cubist Systematic Strategies
Connecticut
-$6.28K
4
XT
XTX Topco
Cayman Islands
-$2.97K
5
UBS Group
UBS Group
Switzerland
-$779
Name Holding Trade Value Shares
Change 		Shares
Change %
SS
26
SBI Securities
Japan
$2 – – –
Millennium Management
27
Millennium Management
New York
– -$13.2K -3,003 Closed
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– -$9.16K -2,078 Closed
CSS
29
Cubist Systematic Strategies
Connecticut
– -$6.28K -1,424 Closed
1
2